Segall Bryant & Hamill, LLC Palatin Technologies Inc Transaction History

Segall Bryant & Hamill, LLC

  • $7.16 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 11, 2020
SELL
$0.75 - $0.89 $8,988 - $10,666
-11,985 Closed
0 $0
Q3 2019

Nov 12, 2019
BUY
$0.78 - $1.09 $9,348 - $13,063
11,985 New
11,985 $10,000

Others Institutions Holding PTN

# of Institutions
1
Shares Held
2.94K
Call Options Held
0
Put Options Held
0
View Full List

About PALATIN TECHNOLOGIES INC

PTN Quotes by TradingView
  • Ticker PTN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,290,480
  • Market Cap $8.83M
  • Description
  • Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...
More about PTN
Track This Portfolio

Track Segall Bryant & Hamill, LLC Portfolio

Follow Segall Bryant & Hamill, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email